大洋集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1991） 自願公告 訂立貸款融資協議 本 公 告 乃 由 大 洋 集 團 控 股 有 限 公 司（「本公司」）自 願 作 出。 茲提述本公司日期為二零二六年三月二十三日有關針對本公司提出的清盤呈 請 之 公 告（「該公告」）。除 非 另 有 界 定，本 公 告 所 用 詞 彙 與 該 公 告 所 界 定 者 具 有 相 同 涵 義。 本 公 司 董 事 會（「董事會」）謹 此 宣 佈，於 二 零 二 六 年 三 月 二 十 七 日（交 易 時 段 後）， 本 公 司（作 為 借 款 人）與 亞 太 科 技 發 展 投 資 銀 行 有 限 公 司（作 為 貸 款 人，「貸款人」） 訂 立 貸 款 融 資 協 議（「貸款融資協議」），據 此，貸 款 人 同 意 向 本 公 司 提 供 總 額 為 52,000,000港 元 的 貸 款 融 資（「貸款融資」）。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 就 因 本 公 ...

Core Viewpoint - The company intends to sell all issued share capital of a subsidiary to Mr. Guo Guangxiong for HKD 1.00, aiming to alleviate financial burdens and reallocate resources more efficiently to its remaining tobacco flavor business [1] Group 1: Sale Details - The sale involves a subsidiary that holds full ownership of nine companies established in China, primarily engaged in financial guarantee, loan financing, micro-lending, loan referral, and consulting services [1] - The subsidiary has ceased its loan financing operations in Beijing due to adverse impacts from the Chinese economy and business environment, and has not generated any revenue since 2024 [1] Group 2: Financial Implications - The board believes that the proposed sale will help reduce the financial burden on the group, which has recorded losses for several consecutive years and is in a net debt position [1] - The sale is expected to free up working capital that was previously allocated to the subsidiary, allowing for more efficient resource distribution to the company's other business segments [1]

Core Viewpoint - Great China Financial (00431) plans to sell all issued share capital of He Feng Limited to Mr. Guo Guangxiong for HKD 1.00, aiming to alleviate financial burdens from its loss-making subsidiary [1] Group 1: Sale Details - The sale involves a subsidiary that holds full ownership of nine companies established in China, primarily engaged in financial guarantee, loan financing, micro-lending, loan referral, and consulting services [1] - The subsidiary has ceased its loan financing operations in Beijing due to adverse impacts from the Chinese economy and business environment, and has not generated any revenue since 2024 [1] Group 2: Financial Implications - The board believes that the proposed sale will help reduce the financial burden on the group, which has recorded losses for several consecutive years and is in a net debt position [1] - The sale is expected to free up working capital that was previously allocated to the subsidiary, allowing for more efficient resource allocation to the group's remaining business, specifically in the tobacco flavoring sector [1]

Group 1 - The core announcement is that Pizu Industrial, a wholly-owned subsidiary of the company, has entered into a loan agreement with Kanzi Diyor, agreeing to provide a loan with a principal limit of up to $80 million, subject to the actual disbursement amount [1]

Core Viewpoint - Haosen Financial Technology (03848) has announced a loan financing agreement with Huizhou Wanyelung Glass Technology Co., Ltd., involving a loan amount of RMB 14.66 million at an annual interest rate of 21.6% for a duration of 12 months [1] Group 1 - The loan amount is RMB 14.66 million, which is approximately 2.1 million USD [1] - The annual interest rate for the loan is set at 21.6%, reflecting the financial background of the borrower and current market conditions [1] - The loan agreement is established for a term of 12 months, indicating a short-term financing strategy [1]

Core Viewpoint - Haosen Financial Technology (03848.HK) announced a loan financing agreement with a borrower, amounting to RMB 14.66 million (approximately HKD 16.51 million) with an annual interest rate of 21.6% for a term of 12 months [1] Group 1 - The loan amount is RMB 14.66 million, equivalent to approximately HKD 16.51 million as of the announcement date [1] - The annual interest rate for the loan is set at 21.6% [1] - The loan agreement is established for a duration of 12 months [1] Group 2 - The interest rate was determined based on the borrower's financial background, previous lending assessments, the lender's funding costs, and prevailing market rates [1]

Core Viewpoint - Haosen Financial Technology (03848) has announced a loan financing agreement with Huizhou Wanyelong Glass Technology Co., Ltd., amounting to RMB 14.66 million at an annual interest rate of 21.6% for a term of 12 months [1] Group 1 - The loan amount is RMB 14.66 million, which is approximately USD 2.1 million [1] - The annual interest rate for the loan is set at 21.6%, reflecting the financial background of the borrower and current market conditions [1] - The loan agreement is established for a duration of 12 months, starting from the date of the agreement [1]

Core Viewpoint - The company is undergoing a significant restructuring by selling its indirect wholly-owned subsidiary, China Hengjia Capital Group Co., Ltd., to address ongoing litigation and operational challenges, with the sale price set at RMB 70 million [1][2]. Group 1: Sale Agreement and Financial Implications - The sale agreement involves the seller, a wholly-owned subsidiary of the company, and the buyer, Sheen Nation Holdings Limited, with the transaction aimed at resolving disputes related to Hong Kong Hengjia [1]. - China Hengjia Capital Group primarily engages in investment holding and financial leasing, holding approximately 51.39% equity in Beijing Hengjia, which has faced operational losses due to stricter regulatory frameworks and challenging market conditions [1]. - The company lost actual control over Beijing Hengjia since August 2023 due to disputes with its Chinese joint venture partner, leading to operational deadlock and ongoing litigation [1]. Group 2: Litigation and Strategic Exit - The board has considered various solutions, including potential judicial liquidation, which could take years and incur substantial legal costs without guaranteed compensation [2]. - The ongoing litigation from Beijing Hengjia demands the company to cover approximately $20 million in unpaid capital contributions, making the sale a strategic exit to eliminate uncertainties related to the lawsuit [2]. - The sale allows the company to focus on its core business lines and utilize the proceeds to expand its loan financing and securities investment operations in Hong Kong, as well as enhance its distribution of healthcare, pet products, and health food manufacturing [2].

Core Viewpoint - The company is undergoing a significant restructuring by selling its indirect wholly-owned subsidiary, China Hengjia Capital Group Co., Ltd., to address ongoing litigation and operational challenges, with the sale price set at RMB 70 million [1][2]. Group 1: Sale Agreement and Financial Details - The sale agreement involves the seller, a wholly-owned subsidiary of the company, and the buyer, Sheen Nation Holdings Limited, with the transaction valued at RMB 70 million [1]. - China Hengjia Capital Group primarily engages in investment holding and financial leasing, holding approximately 51.39% of Beijing Hengjia's equity, classified as equity investments measured at fair value through other comprehensive income [1]. Group 2: Operational Challenges and Litigation - The subsidiary has faced operational losses in recent years due to stricter regulatory frameworks and challenging market conditions in China [1]. - Since August 2023, the company lost actual control over Beijing Hengjia due to disputes with its Chinese joint venture partner, leading to operational stagnation and ongoing litigation [1]. Group 3: Strategic Implications of the Sale - The board has considered various solutions, including potential judicial liquidation, but found them uncertain and costly, prompting the decision to proceed with the sale as a means to eliminate litigation-related uncertainties [2]. - The sale provides an immediate exit opportunity to divest non-core underperforming assets and allows the company to focus on more promising and manageable business lines [2]. - Proceeds from the sale are intended to be used to expand the company's loan financing and securities investment business in Hong Kong, as well as to enhance operations in healthcare, pet products distribution, and health food manufacturing and sales [2].

Group 1 - The core point of the article is that Haosen Financial Technology (03848) has entered into a loan financing agreement with borrower Deng Jianhua, involving a loan amount of RMB 33.3 million at an annual interest rate of 9% for a term of 15 months, starting from the date of the agreement [1] Group 2 - The loan financing agreement is established through Haosen's indirect wholly-owned subsidiary, Haosen Microfinance [1] - The agreement is set to mature on December 17, 2025, indicating a medium-term financial commitment [1] - The interest rate of 9% reflects the company's pricing strategy in the microfinance sector [1]